Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL51470

O=S(=O)([O-])C(F)(F)F.c1ccc([S+](c2ccccc2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.39
LMNA P02545 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
PTPN1 P18031 3/20 0.36
KAT6A Q92794 1/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA9 Q16790 3/20 0.35
GABRB1 P18505 1/20 0.34
GABRB2 P47870 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTGS2 P35354 1/20 0.34
ATM Q13315 1/20 0.34
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL6118365 0.87 GPR3 (0.48) GPR3PTPN1CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL37032 0.85 GPR3 (0.50) GPR3PTPN1CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL31155703 0.85 GPR3 (0.50) GPR3PTPN1CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL10008137 0.83 GPR3 (0.48) GPR3PTPN1CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL30536275 0.83 L3MBTL1 (0.40) GPR3LMNAL3MBTL1PTPN1CA1
SCHEMBL7708849 0.82 CA1 (0.31) PTPN1CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL3367202 0.81 PGR (0.46) LMNACA1CA2CA9SMN1; SMN2
SCHEMBL7702865 0.81 PTPN1 (0.30) PTPN1GABRB1GABRB2
SCHEMBL29404356 0.81 CYP2A6 (0.41) CA1CA2CA9SMN1; SMN2
SCHEMBL245975 0.81 CYP2A6 (0.41) CA1CA2CA9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129491-B2 Siloxane resin coating DOW CORNING CORPORATION (US) 2012-03-06 US claimed
US-20110034629-A1 SILOXANE RESIN COATING DOW CORNING CORPORATION 2011-02-10 US claimed
EP-1846479-A2 SILOXANE RESIN COATING Dow Corning Corporation (US) 2007-10-24 EP claimed
WO-2006065310-A2 SILOXANE RESIN COATING DOW CORNING CORPORATION (US) 2006-06-22 WO claimed
US-10717209-B2 Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom LIQUIDIA TECHNOLOGIES, INC. (US) 2020-07-21 US disclosed
EP-1825330-B1 METHOD FOR FORMING ANTI-REFLECTIVE COATING DOW SILICONES CORP (US) 2019-04-24 EP disclosed
US-9918921-B2 Methods for shaping fibrous material and treatment compositions therefor THE PROCTER & GAMBLE COMPANY (US) 2018-03-20 US disclosed
US-9877559-B2 Methods for shaping fibrous material and treatment compositions therefor THE PROCTER & GAMBLE COMANY (US) 2018-01-30 US disclosed
EP-2117725-B1 METHOD FOR FABRICATING LAMINATE NANOMOLDS LIQUIDIA TECH INC (US) 2017-10-11 EP disclosed
US-20170259461-A1 Methods and Materials for Fabricating Laminate Nanomolds and Nanoparticles Therefrom LIQUIDIA TECHNOLOGIES, INC. (US) 2017-09-14 US disclosed
US-9751070-B2 Structure modifying apparatus THE PROCTER & GAMBLE COMPANY (US) 2017-09-05 US disclosed
EP-3191183-A1 STRUCTURE MODIFYING APPARATUS The Procter and Gamble Company (US) 2017-07-19 EP disclosed
WO-2006065310-A2 SILOXANE RESIN COATING DOW CORNING CORPORATION (US) 2006-06-22 WO disclosed
EP-1601729-B1 INK JET INK COMPOSITION AND METHOD FOR SECURITY MAKING VIDEOJET TECHNOLOGIES INC (US) 2006-06-21 EP disclosed
US-20060128031-A1 Addressable recovery of bound analytes from an evanescent wave sensor AGILENT TECHNOLOGIES, INC. 2006-06-15 US disclosed
WO-2006018640-A1 MULTI-COLOUR PRINTING DATALASE LTD. (GB) 2006-02-23 WO disclosed
US-20050287816-A1 Methods of forming patterned photoresist layers over semiconductor substrates MICRON TECHNOLOGY, INC. 2005-12-29 US disclosed
WO-2005084191-A2 FUNCTIONAL MATERIALS AND NOVEL METHODS FOR THE FABRICATION OF MICROFLUIDIC DEVICES THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2005-09-15 WO disclosed
US-20050203069-A1 Nitric oxide-releasing molecules NOXILIZER, INC. 2005-09-15 US disclosed
WO-2005081753-A2 NITRIC OXIDE-RELEASING MOLECULES NOXILIZER, INC. (US) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203069-A1 Nitric oxide-releasing molecules NOS2, NOS1, NOS3 GPR3 1020/4885LMNA 4304/4885L3MBTL1 4514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.